{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,25]],"date-time":"2026-08-25T18:38:45Z","timestamp":1787683125684,"version":"build-2784847793"},"reference-count":235,"publisher":"MDPI AG","issue":"2","license":[{"start":{"date-parts":[[2026,1,21]],"date-time":"2026-01-21T00:00:00Z","timestamp":1768953600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"NIH\/NIAID","award":["R01Al175439-01"],"award-info":[{"award-number":["R01Al175439-01"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["IJMS"],"abstract":"<jats:p>Mosquito-borne flaviviruses, including Dengue virus (DENV), Japanese encephalitis virus (JEV), West Nile virus (WNV), Yellow fever virus (YFV), and Zika virus (ZIKV), continue to present a significant threat to public health worldwide. In 2024, these viruses accounted for 11,717 reported cases in the United States and more than 7.6 million cases globally. As of early 2025, according to CDC data, 1830 cases of dengue had already been reported, with 1584 transmitted locally within the U.S. Despite the considerable burden that these diseases pose, no specific antiviral treatments exist. A very limited number of virus-specific vaccines have been licensed, such as those for YFV, JEV, and, with specific constraints, for DENV. To date, no pan-flavivirus vaccine is available. This review examines the potential of emerging vaccine platforms\u2014particularly messenger RNA and virus-like particles\u2014as promising tools in the pursuit of a broadly protective flavivirus vaccine. We analyze current strategies for inducing cross-neutralizing immune responses and discuss how these technologies could support the presentation of conserved quaternary epitope conformations, which are increasingly recognized as critical targets for establishing potent immune responses. We review key advances in virology, immune response, and immunogen delivery systems to highlight the potential for developing a pan-flavivirus vaccine.<\/jats:p>","DOI":"10.3390\/ijms27021081","type":"journal-article","created":{"date-parts":[[2026,1,21]],"date-time":"2026-01-21T15:31:46Z","timestamp":1769009506000},"page":"1081","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Opportunities and Challenges of mRNA and VLP Technologies for Pan-Flavivirus Vaccine Development: Focus on Conserved Quaternary Epitope Conformations"],"prefix":"10.3390","volume":"27","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4521-143X","authenticated-orcid":false,"given":"Eduar Fernando","family":"Pinzon Burgos","sequence":"first","affiliation":[{"name":"Division of Clinical Care and Research, Institute of Human Virology, University of Maryland School of Medicine, Baltimore, MD 21201, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sigrid","family":"Camacho Ortega","sequence":"additional","affiliation":[{"name":"Division of Clinical Care and Research, Institute of Human Virology, University of Maryland School of Medicine, Baltimore, MD 21201, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ben","family":"Atkinson","sequence":"additional","affiliation":[{"name":"Division of Clinical Care and Research, Institute of Human Virology, University of Maryland School of Medicine, Baltimore, MD 21201, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7579-4672","authenticated-orcid":false,"given":"Joel V.","family":"Chua","sequence":"additional","affiliation":[{"name":"Division of Clinical Care and Research, Institute of Human Virology, University of Maryland School of Medicine, Baltimore, MD 21201, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7468-8504","authenticated-orcid":false,"given":"Alonso","family":"Heredia","sequence":"additional","affiliation":[{"name":"Division of Clinical Care and Research, Institute of Human Virology, University of Maryland School of Medicine, Baltimore, MD 21201, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2026,1,21]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1016\/S0140-6736(08)60238-X","article-title":"Pathogenic Flaviviruses","volume":"371","author":"Gould","year":"2008","journal-title":"Lancet"},{"key":"ref_2","doi-asserted-by":"crossref","unstructured":"Liang, Y., and Dai, X. (2024). The Global Incidence and Trends of Three Common Flavivirus Infections (Dengue, Yellow Fever, and Zika) from 2011 to 2021. Front. Microbiol., 15.","DOI":"10.3389\/fmicb.2024.1458166"},{"key":"ref_3","unstructured":"(2025, July 08). CDC Current Dengue Outbreak, Available online: https:\/\/www.cdc.gov\/dengue\/outbreaks\/2024\/index.html."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"e1229","DOI":"10.1016\/S2214-109X(24)00226-2","article-title":"Delivering Safe Dengue Vaccines","volume":"12","author":"Halstead","year":"2024","journal-title":"Lancet Glob. Health"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1038\/s41541-022-00552-3","article-title":"Yellow Fever Resurgence: An Avoidable Crisis?","volume":"7","author":"Lindsey","year":"2022","journal-title":"npj Vaccines"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1038\/s41541-023-00658-2","article-title":"Is New Dengue Vaccine Efficacy Data a Relief or Cause for Concern?","volume":"8","author":"Thomas","year":"2023","journal-title":"npj Vaccines"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"1195","DOI":"10.1056\/NEJMoa1506223","article-title":"Efficacy and Long-Term Safety of a Dengue Vaccine in Regions of Endemic Disease","volume":"373","author":"Hadinegoro","year":"2015","journal-title":"N. Engl. J. Med."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"741","DOI":"10.4269\/ajtmh.16-0222","article-title":"Licensed Dengue Vaccine: Public Health Conundrum and Scientific Challenge","volume":"95","author":"Halstead","year":"2016","journal-title":"Am. J. Trop. Med. Hyg."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1128\/microbiolspec.AID-0022-2014","article-title":"Dengue Antibody-Dependent Enhancement: Knowns and Unknowns","volume":"2","author":"Halstead","year":"2014","journal-title":"Microbiol. Spectr."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"e257","DOI":"10.1016\/S2214-109X(23)00522-3","article-title":"Long-Term Efficacy and Safety of a Tetravalent Dengue Vaccine (TAK-003): 4\u00b75-Year Results from a Phase 3, Randomised, Double-Blind, Placebo-Controlled Trial","volume":"12","author":"Tricou","year":"2024","journal-title":"Lancet Glob. Health"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"2663","DOI":"10.1038\/s41591-025-03771-y","article-title":"Efficacy, Public Health Impact and Optimal Use of the Takeda Dengue Vaccine","volume":"31","author":"Ferguson","year":"2025","journal-title":"Nat. Med."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1056\/NEJMoa2301790","article-title":"Live, Attenuated, Tetravalent Butantan\u2013Dengue Vaccine in Children and Adults","volume":"390","author":"Cintra","year":"2024","journal-title":"N. Engl. J. Med."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"1234","DOI":"10.1016\/S1473-3099(24)00376-1","article-title":"Efficacy and Safety of Butantan-DV in Participants Aged 2\u201359 Years through an Extended Follow-up: Results from a Double-Blind, Randomised, Placebo-Controlled, Phase 3, Multicentre Trial in Brazil","volume":"24","author":"Nogueira","year":"2024","journal-title":"Lancet Infect. Dis."},{"key":"ref_14","unstructured":"Pan American Health Organization (2025, November 06). Public Health Risk of Yellow Fever Remains High in the Americas Due to Continued Occurrence of Human Cases\u2014PAHO\/WHO. Available online: https:\/\/www.paho.org\/en\/news\/27-5-2025-public-health-risk-yellow-fever-remains-high-americas-due-continued-occurrence-human."},{"key":"ref_15","unstructured":"World Health Organization (2025, July 09). Yellow Fever\u2014Region of the Americas. Available online: https:\/\/www.who.int\/emergencies\/disease-outbreak-news\/item\/2025-DON570."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"e29","DOI":"10.26633\/RPSP.2019.29","article-title":"Yellow Fever Outbreak in a Rural-Urban Mixed Community of Esp\u00edrito Santo, Brazil: Epidemiological Aspects","volume":"43","author":"Moussallem","year":"2019","journal-title":"Rev. Panam. Salud Publica"},{"key":"ref_17","first-page":"101144","article-title":"Colombian Consensus on the Care of Critically Ill Patients with Suspected or Confirmed Severe Yellow Fever","volume":"48","year":"2025","journal-title":"Lancet Reg. Health\u2013Am."},{"key":"ref_18","doi-asserted-by":"crossref","unstructured":"Huber, J.H., Childs, M.L., Caldwell, J.M., and Mordecai, E.A. (2018). Seasonal Temperature Variation Influences Climate Suitability for Dengue, Chikungunya, and Zika Transmission. PLoS Neglected Trop. Dis., 12.","DOI":"10.1371\/journal.pntd.0006451"},{"key":"ref_19","doi-asserted-by":"crossref","unstructured":"Wieten, R.W., Jonker, E.F.F., van Leeuwen, E.M.M., Remmerswaal, E.B.M., Ten Berge, I.J.M., de Visser, A.W., van Genderen, P.J.J., Goorhuis, A., Visser, L.G., and Grobusch, M.P. (2016). A Single 17D Yellow Fever Vaccination Provides Lifelong Immunity; Characterization of Yellow-Fever-Specific Neutralizing Antibody and T-Cell Responses after Vaccination. PLoS ONE, 11.","DOI":"10.1371\/journal.pone.0149871"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"3827","DOI":"10.1016\/j.vaccine.2010.03.023","article-title":"Inactivated Yellow Fever 17D Vaccine: Development and Nonclinical Safety, Immunogenicity and Protective Activity","volume":"28","author":"Monath","year":"2010","journal-title":"Vaccine"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"1696","DOI":"10.1038\/s41467-024-45806-x","article-title":"Prior Flavivirus Immunity Skews the Yellow Fever Vaccine Response to Cross-Reactive Antibodies with Potential to Enhance Dengue Virus Infection","volume":"15","author":"Luppa","year":"2024","journal-title":"Nat. Commun."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1007\/s11908-017-0566-9","article-title":"Live Attenuated Yellow Fever 17D Vaccine: A Legacy Vaccine Still Controlling Outbreaks in Modern Day","volume":"19","author":"Collins","year":"2017","journal-title":"Curr. Infect. Dis. Rep."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.puhe.2017.05.008","article-title":"The Rise of Zika Infection and Microcephaly: What Can We Learn from a Public Health Emergency?","volume":"150","author":"McCloskey","year":"2017","journal-title":"Public Health"},{"key":"ref_24","unstructured":"Pan American Health Organization (2025, July 30). Zika: Analysis by Country\u2014PAHO\/WHO. Available online: https:\/\/www.paho.org\/en\/arbo-portal\/zika-data-and-analysis\/zika-analysis-country."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1016\/S0140-6736(17)33106-9","article-title":"Safety and Immunogenicity of a Purified Inactivated Zika Virus Vaccine Candidate: Preliminary Aggregate Results from Three Phase 1a Randomized, Double-Blind, Placebo Controlled Clinical Trials","volume":"391","author":"Modjarrad","year":"2018","journal-title":"Lancet"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"1282","DOI":"10.1016\/S1473-3099(20)30733-7","article-title":"Safety and Immunogenicity of a Purified Inactivated Zika Virus Vaccine Candidate in Healthy Adults: An Observer-Blind, Randomised, Phase 1 Trial","volume":"21","author":"Han","year":"2021","journal-title":"Lancet Infect. Dis."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1016\/S0140-6736(17)33105-7","article-title":"Safety, Tolerability, and Immunogenicity of Two Zika Virus DNA Vaccine Candidates in Healthy Adults: Randomised, Open-Label, Phase 1 Clinical Trials","volume":"391","author":"Gaudinski","year":"2018","journal-title":"Lancet"},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"1102","DOI":"10.1038\/ni.3515","article-title":"Dengue Virus Sero-Cross-Reactivity Drives Antibody-Dependent Enhancement of Infection with Zika Virus","volume":"17","author":"Dejnirattisai","year":"2016","journal-title":"Nat. Immunol."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1126\/science.aaf8505","article-title":"Specificity, Cross-Reactivity, and Function of Antibodies Elicited by Zika Virus Infection","volume":"353","author":"Stettler","year":"2016","journal-title":"Science"},{"key":"ref_30","doi-asserted-by":"crossref","unstructured":"Li, X., Gao, X., Ren, Z., Cao, Y., Wang, J., and Liang, G. (2014). A Spatial and Temporal Analysis of Japanese Encephalitis in Mainland China, 1963\u20131975: A Period without Japanese Encephalitis Vaccination. PLoS ONE, 9.","DOI":"10.1371\/journal.pone.0099183"},{"key":"ref_31","doi-asserted-by":"crossref","unstructured":"Upreti, S.R., Lindsey, N.P., Bohara, R., Choudhary, G.R., Shakya, S., Gautam, M., Giri, J.N., Fischer, M., and Hills, S.L. (2017). Updated Estimation of the Impact of a Japanese Encephalitis Immunization Program with Live, Attenuated SA 14-14-2 Vaccine in Nepal. PLoS Neglected Trop. Dis., 11.","DOI":"10.1371\/journal.pntd.0005866"},{"key":"ref_32","doi-asserted-by":"crossref","unstructured":"Letson, G.W., Marfin, A.A., Mooney, J., Minh, H.V., and Hills, S.L. (2024). Impact of Vaccination against Japanese Encephalitis in Endemic Countries. PLoS Neglected Trop. Dis., 18.","DOI":"10.1371\/journal.pntd.0012390"},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"1501","DOI":"10.1586\/erv.09.112","article-title":"Ixiaro: A New Vaccine against Japanese Encephalitis","volume":"8","author":"Jelinek","year":"2009","journal-title":"Expert Rev. Vaccines"},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"1","DOI":"10.15585\/mmwr.rr6802a1","article-title":"Japanese Encephalitis Vaccine: Recommendations of the Advisory Committee on Immunization Practices","volume":"68","author":"Hills","year":"2019","journal-title":"MMWR Recomm. Rep."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"101176","DOI":"10.1016\/j.lanmic.2025.101176","article-title":"Identifying Genomic Surveillance Gaps in Africa for the Global Public Health Response to West Nile Virus: A Systematic Review","volume":"6","author":"Moir","year":"2025","journal-title":"Lancet Microbe"},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"25016","DOI":"10.1038\/s41598-025-09284-5","article-title":"Rising Temperatures Contribute to West Nile Virus Diversification and Increased Transmission Potential","volume":"15","author":"Fay","year":"2025","journal-title":"Sci. Rep."},{"key":"ref_37","first-page":"249","article-title":"Evaluation of the Efficacy Provided by a Recombinant Canarypox-Vectored Equine West Nile Virus Vaccine against an Experimental West Nile Virus Intrathecal Challenge in Horses","volume":"7","author":"Siger","year":"2006","journal-title":"Vet. Ther."},{"key":"ref_38","first-page":"221","article-title":"Equine Vaccine for West Nile Virus","volume":"114","author":"Ng","year":"2003","journal-title":"Dev. Biol."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"3048","DOI":"10.3390\/v5123048","article-title":"Preclinical and Clinical Development of a YFV 17 D-Based Chimeric Vaccine against West Nile Virus","volume":"5","author":"Dayan","year":"2013","journal-title":"Viruses"},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"5772","DOI":"10.1016\/j.vaccine.2013.07.064","article-title":"The Live Attenuated Chimeric Vaccine rWN\/DEN4\u039430 Is Well-Tolerated and Immunogenic in Healthy Flavivirus-Na\u00efve Adult Volunteers","volume":"31","author":"Durbin","year":"2013","journal-title":"Vaccine"},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"1633","DOI":"10.1056\/NEJMp2301816","article-title":"Combating West Nile Virus Disease\u2014Time to Revisit Vaccination","volume":"388","author":"Gould","year":"2023","journal-title":"N. Engl. J. Med."},{"key":"ref_42","doi-asserted-by":"crossref","unstructured":"Wei\u00df, R., Issmail, L., Rockstroh, A., Grunwald, T., Fertey, J., and Ulbert, S. (2023). Immunization with Different Recombinant West Nile Virus Envelope Proteins Induces Varying Levels of Serological Cross-Reactivity and Protection from Infection. Front. Cell. Infect. Microbiol., 13.","DOI":"10.3389\/fcimb.2023.1279147"},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1126\/science.aaf5316","article-title":"The 3.8 \u00c5 Resolution Cryo-EM Structure of Zika Virus","volume":"352","author":"Sirohi","year":"2016","journal-title":"Science"},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"e01461-15","DOI":"10.1128\/mBio.01461-15","article-title":"A New Quaternary Structure Epitope on Dengue Virus Serotype 2 Is the Target of Durable Type-Specific Neutralizing Antibodies","volume":"6","author":"Gallichotte","year":"2015","journal-title":"mBio"},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"2442","DOI":"10.1016\/j.immuni.2023.09.003","article-title":"Antibodies Targeting a Quaternary Site on SARS-CoV-2 Spike Glycoprotein Prevent Viral Receptor Engagement by Conformational Locking","volume":"56","author":"Liu","year":"2023","journal-title":"Immunity"},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"e00873-13","DOI":"10.1128\/mBio.00873-13","article-title":"The Potent and Broadly Neutralizing Human Dengue Virus-Specific Monoclonal Antibody 1C19 Reveals a Unique Cross-Reactive Epitope on the Bc Loop of Domain II of the Envelope Protein","volume":"4","author":"Smith","year":"2013","journal-title":"mBio"},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1038\/nature19780","article-title":"Erratum: Structural Basis of Potent Zika\u2013Dengue Virus Antibody Cross-Neutralization","volume":"539","author":"Dejnirattisai","year":"2016","journal-title":"Nature"},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"e02322","DOI":"10.1128\/jvi.02322-24","article-title":"Virus-like Particle Vaccine with Authentic Quaternary Epitopes Protects against Zika Virus-Induced Viremia and Testicular Damage","volume":"99","author":"Abbo","year":"2025","journal-title":"J. Virol."},{"key":"ref_49","doi-asserted-by":"crossref","unstructured":"Kheirvari, M., Liu, H., and Tumban, E. (2023). Virus-like Particle Vaccines and Platforms for Vaccine Development. Viruses, 15.","DOI":"10.3390\/v15051109"},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1038\/s41423-022-00897-8","article-title":"Virus-like Particle Vaccinology, from Bench to Bedside","volume":"19","author":"Mohsen","year":"2022","journal-title":"Cell. Mol. Immunol."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"107622","DOI":"10.1016\/j.intimp.2021.107622","article-title":"Potential SARS-CoV-2 Vaccines: Concept, Progress, and Challenges","volume":"97","author":"Hosseini","year":"2021","journal-title":"Int. Immunopharmacol."},{"key":"ref_52","doi-asserted-by":"crossref","unstructured":"Boigard, H., Alimova, A., Martin, G.R., Katz, A., Gottlieb, P., and Galarza, J.M. (2017). Zika Virus-like Particle (VLP) Based Vaccine. PLoS Neglected Trop. Dis., 11.","DOI":"10.1371\/journal.pntd.0005608"},{"key":"ref_53","doi-asserted-by":"crossref","unstructured":"Haghmorad, D., Eslami, M., Orooji, N., Halabitska, I., Kamyshna, I., Kamyshnyi, O., and Oksenych, V. (2025). mRNA Vaccine Platforms: Linking Infectious Disease Prevention and Cancer Immunotherapy. Front. Bioeng. Biotechnol., 13.","DOI":"10.3389\/fbioe.2025.1547025"},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1038\/nrd.2017.243","article-title":"mRNA Vaccines\u2014A New Era in Vaccinology","volume":"17","author":"Pardi","year":"2018","journal-title":"Nat. Rev. Drug Discov."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"3382","DOI":"10.1016\/j.celrep.2018.11.082","article-title":"An mRNA Vaccine Protects Mice against Multiple Tick-Transmitted Flavivirus Infections","volume":"25","author":"VanBlargan","year":"2018","journal-title":"Cell Rep."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1126\/science.4023707","article-title":"Nucleotide Sequence of Yellow Fever Virus: Implications for Flavivirus Gene Expression and Evolution","volume":"229","author":"Rice","year":"1985","journal-title":"Science"},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1038\/sj.emboj.7600064","article-title":"Structure of a Flavivirus Envelope Glycoprotein in Its Low-pH-Induced Membrane Fusion Conformation","volume":"23","author":"Bressanelli","year":"2004","journal-title":"EMBO J."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"7769","DOI":"10.1128\/JVI.75.16.7769-7773.2001","article-title":"Monoclonal Antibodies That Bind to Domain III of Dengue Virus E Glycoprotein are the Most Efficient Blockers of Virus Adsorption to Vero Cells","volume":"75","author":"Crill","year":"2001","journal-title":"J. Virol."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"4268","DOI":"10.1128\/JVI.75.9.4268-4275.2001","article-title":"Mutational Evidence for an Internal Fusion Peptide in Flavivirus Envelope Protein E","volume":"75","author":"Allison","year":"2001","journal-title":"J. Virol."},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"6986","DOI":"10.1073\/pnas.0832193100","article-title":"A Ligand-Binding Pocket in the Dengue Virus Envelope Glycoprotein","volume":"100","author":"Modis","year":"2003","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"1607","DOI":"10.1016\/j.str.2004.06.019","article-title":"Conformational Changes of the Flavivirus E Glycoprotein","volume":"12","author":"Zhang","year":"2004","journal-title":"Structure"},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"46007","DOI":"10.1074\/jbc.M307776200","article-title":"Structural Basis of a Flavivirus Recognized by Its Neutralizing Antibody: Solution Structure of the Domain III of the Japanese Encephalitis Virus Envelope Protein","volume":"278","author":"Wu","year":"2003","journal-title":"J. Biol. Chem."},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"1185","DOI":"10.1099\/vir.0.040238-0","article-title":"Mutation Analysis of the Cross-Reactive Epitopes of Japanese Encephalitis Virus Envelope Glycoprotein","volume":"93","author":"Chiou","year":"2012","journal-title":"J. Gen. Virol."},{"key":"ref_64","doi-asserted-by":"crossref","unstructured":"Yu, K., Sheng, Z.-Z., Huang, B., Ma, X., Li, Y., Yuan, X., Qin, Z., Wang, D., Chakravarty, S., and Li, F. (2013). Structural, Antigenic, and Evolutionary Characterizations of the Envelope Protein of Newly Emerging Duck Tembusu Virus. PLoS ONE, 8.","DOI":"10.1371\/journal.pone.0071319"},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"13975","DOI":"10.1128\/JVI.78.24.13975-13986.2004","article-title":"Localization and Characterization of Flavivirus Envelope Glycoprotein Cross-Reactive Epitopes","volume":"78","author":"Crill","year":"2004","journal-title":"J. Virol."},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1177\/2040206616653873","article-title":"Predicting Zika Virus Structural Biology: Challenges and Opportunities for Intervention","volume":"24","author":"Cox","year":"2015","journal-title":"Antivir. Chem. Chemother."},{"key":"ref_67","first-page":"1150","article-title":"Computational Analysis of Perturbations in the Post-Fusion Dengue Virus Envelope Protein Highlights Known Epitopes and Conserved Residues in the Zika Virus","volume":"5","author":"Chakraborty","year":"2016","journal-title":"F1000Research"},{"key":"ref_68","doi-asserted-by":"crossref","unstructured":"Rockstroh, A., Barzon, L., Pacenti, M., Pal\u00f9, G., Niedrig, M., and Ulbert, S. (2015). Recombinant Envelope-Proteins with Mutations in the Conserved Fusion Loop Allow Specific Serological Diagnosis of Dengue-Infections. PLoS Neglected Trop. Dis., 9.","DOI":"10.1371\/journal.pntd.0004218"},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1016\/j.vaccine.2012.12.016","article-title":"Virus-like Particles Displaying Envelope Domain III of Dengue Virus Type 2 Induce Virus-Specific Antibody Response in Mice","volume":"31","author":"Arora","year":"2013","journal-title":"Vaccine"},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"2648","DOI":"10.1128\/JVI.78.5.2648-2652.2004","article-title":"Contribution of Disulfide Bridging to Epitope Expression of the Dengue Type 2 Virus Envelope Glycoprotein","volume":"78","author":"Roehrig","year":"2004","journal-title":"J. Virol."},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"36288","DOI":"10.1038\/srep36288","article-title":"Identification of a New Broadly Cross-Reactive Epitope within Domain III of the Duck Tembusu Virus E Protein","volume":"6","author":"Li","year":"2016","journal-title":"Sci. Rep."},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1016\/j.biologicals.2010.07.004","article-title":"Domain III Peptides from Flavivirus Envelope Protein Are Useful Antigens for Serologic Diagnosis and Targets for Immunization","volume":"38","author":"Silva","year":"2010","journal-title":"Biologicals"},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"4524","DOI":"10.1038\/s41598-017-04767-6","article-title":"In Vitro Assembly and Stabilization of Dengue and Zika Virus Envelope Protein Homo-Dimers","volume":"7","author":"Metz","year":"2017","journal-title":"Sci. Rep."},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"8482","DOI":"10.1128\/JVI.00660-09","article-title":"Impact of Quaternary Organization on the Antigenic Structure of the Tick-Borne Encephalitis Virus Envelope Glycoprotein E","volume":"83","author":"Kiermayr","year":"2009","journal-title":"J. Virol."},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"1016","DOI":"10.1016\/j.cell.2016.07.020","article-title":"Structural Basis of Zika Virus-Specific Antibody Protection","volume":"166","author":"Zhao","year":"2016","journal-title":"Cell"},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1016\/j.cell.2017.04.024","article-title":"Recurrent Potent Human Neutralizing Antibodies to Zika Virus in Brazil and Mexico","volume":"169","author":"Robbiani","year":"2017","journal-title":"Cell"},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"14722","DOI":"10.1038\/ncomms14722","article-title":"A Human Antibody against Zika Virus Crosslinks the E Protein to Prevent Infection","volume":"8","author":"Hasan","year":"2017","journal-title":"Nat. Commun."},{"key":"ref_78","doi-asserted-by":"crossref","unstructured":"Qian, X., and Qi, Z. (2022). Mosquito-Borne Flaviviruses and Current Therapeutic Advances. Viruses, 14.","DOI":"10.3390\/v14061226"},{"key":"ref_79","doi-asserted-by":"crossref","unstructured":"Pan, Y., Cai, W., Cheng, A., Wang, M., Yin, Z., and Jia, R. (2022). Flaviviruses: Innate Immunity, Inflammasome Activation, Inflammatory Cell Death, and Cytokines. Front. Immunol., 13.","DOI":"10.3389\/fimmu.2022.829433"},{"key":"ref_80","doi-asserted-by":"crossref","unstructured":"Martins, A.S., Martins, I.C., and Santos, N.C. (2018). Methods for Lipid Droplet Biophysical Characterization in Flaviviridae Infections. Front. Microbiol., 9.","DOI":"10.3389\/fmicb.2018.01951"},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"6341","DOI":"10.1038\/ncomms7341","article-title":"A Highly Potent Human Antibody Neutralizes Dengue Virus Serotype 3 by Binding across Three Surface Proteins","volume":"6","author":"Fibriansah","year":"2015","journal-title":"Nat. Commun."},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"18950","DOI":"10.1073\/pnas.1011036107","article-title":"Neutralization of West Nile Virus by Cross-Linking of Its Surface Proteins with Fab Fragments of the Human Monoclonal Antibody CR4354","volume":"107","author":"Kaufmann","year":"2010","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1002\/emmm.201303404","article-title":"A Potent Anti-Dengue Human Antibody Preferentially Recognizes the Conformation of E Protein Monomers Assembled on the Virus Surface","volume":"6","author":"Fibriansah","year":"2014","journal-title":"EMBO Mol. Med."},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"1169","DOI":"10.1016\/j.str.2018.05.006","article-title":"Refinement and Analysis of the Mature Zika Virus Cryo-EM Structure at 3.1 \u00c5 Resolution","volume":"26","author":"Sevvana","year":"2018","journal-title":"Structure"},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"e01396-16","DOI":"10.1128\/mBio.01396-16","article-title":"Zika Virus Is Not Uniquely Stable at Physiological Temperatures Compared to Other Flaviviruses","volume":"7","author":"Goo","year":"2016","journal-title":"mBio"},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1038\/nature18952","article-title":"Vaccine Protection against Zika Virus from Brazil","volume":"536","author":"Larocca","year":"2016","journal-title":"Nature"},{"key":"ref_87","doi-asserted-by":"crossref","unstructured":"Dowd, K.A., Jost, C.A., Durbin, A.P., Whitehead, S.S., and Pierson, T.C. (2011). A Dynamic Landscape for Antibody Binding Modulates Antibody-Mediated Neutralization of West Nile Virus. PLoS Pathog., 7.","DOI":"10.1371\/journal.ppat.1002111"},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1038\/nature14130","article-title":"Recognition Determinants of Broadly Neutralizing Human Antibodies against Dengue Viruses","volume":"520","author":"Rouvinski","year":"2015","journal-title":"Nature"},{"key":"ref_89","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.1038\/ni.3849","article-title":"Human Antibodies to the Dengue Virus E-Dimer Epitope Have Therapeutic Activity against Zika Virus Infection","volume":"18","author":"Fernandez","year":"2017","journal-title":"Nat. Immunol."},{"key":"ref_90","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1038\/nature20564","article-title":"Neutralizing Human Antibodies Prevent Zika Virus Replication and Fetal Disease in Mice","volume":"540","author":"Sapparapu","year":"2016","journal-title":"Nature"},{"key":"ref_91","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1038\/nm1240","article-title":"Development of a Humanized Monoclonal Antibody with Therapeutic Potential against West Nile Virus","volume":"11","author":"Oliphant","year":"2005","journal-title":"Nat. Med."},{"key":"ref_92","doi-asserted-by":"crossref","first-page":"1300","DOI":"10.1086\/508293","article-title":"Humanized Monoclonal Antibody against West Nile Virus Envelope Protein Administered after Neuronal Infection Protects against Lethal Encephalitis in Hamsters","volume":"194","author":"Morrey","year":"2006","journal-title":"J. Infect. Dis."},{"key":"ref_93","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1016\/j.virol.2006.08.047","article-title":"The Neutralizing Antibody Response against West Nile Virus in Naturally Infected Horses","volume":"359","author":"Pierson","year":"2007","journal-title":"Virology"},{"key":"ref_94","doi-asserted-by":"crossref","first-page":"2699","DOI":"10.4049\/jimmunol.178.5.2699","article-title":"Immunization of Flavivirus West Nile Recombinant Envelope Domain III Protein Induced Specific Immune Response and Protection against West Nile Virus Infection","volume":"178","author":"Chu","year":"2007","journal-title":"J. Immunol."},{"key":"ref_95","doi-asserted-by":"crossref","first-page":"e00512","DOI":"10.1128\/mbio.00512-22","article-title":"Isolation of a Potently Neutralizing and Protective Human Monoclonal Antibody Targeting Yellow Fever Virus","volume":"13","author":"Doyle","year":"2022","journal-title":"mBio"},{"key":"ref_96","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1056\/NEJMoa2000226","article-title":"Phase 1 Trial of a Therapeutic Anti\u2013Yellow Fever Virus Human Antibody","volume":"383","author":"Low","year":"2020","journal-title":"N. Engl. J. Med."},{"key":"ref_97","first-page":"100323","article-title":"A Neutralizing-Protective Supersite of Human Monoclonal Antibodies for Yellow Fever Virus","volume":"3","author":"Li","year":"2022","journal-title":"Innovation"},{"key":"ref_98","doi-asserted-by":"crossref","unstructured":"Deng, Y.-Q., Dai, J.-X., Ji, G.-H., Jiang, T., Wang, H.-J., Yang, H., Tan, W.-L., Liu, R., Yu, M., and Ge, B.-X. (2011). A Broadly Flavivirus Cross-Neutralizing Monoclonal Antibody That Recognizes a Novel Epitope within the Fusion Loop of E Protein. PLoS ONE, 6.","DOI":"10.1371\/journal.pone.0016059"},{"key":"ref_99","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1016\/j.chom.2016.04.013","article-title":"Structures of the Zika Virus Envelope Protein and Its Complex with a Flavivirus Broadly Protective Antibody","volume":"19","author":"Dai","year":"2016","journal-title":"Cell Host Microbe"},{"key":"ref_100","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1186\/s12929-023-00938-y","article-title":"Neutralizing Antibodies Targeting a Novel Epitope on Envelope Protein Exhibited Broad Protection against Flavivirus without Risk of Disease Enhancement","volume":"30","author":"Yen","year":"2023","journal-title":"J. Biomed. Sci."},{"key":"ref_101","doi-asserted-by":"crossref","first-page":"6052","DOI":"10.1016\/j.cell.2021.11.010","article-title":"The Epitope Arrangement on Flavivirus Particles Contributes to Mab C10\u2019s Extraordinary Neutralization Breadth across Zika and Dengue Viruses","volume":"184","author":"Sharma","year":"2021","journal-title":"Cell"},{"key":"ref_102","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1016\/j.celrep.2018.06.047","article-title":"RIG-I Recognizes the 5\u2032 Region of Dengue and Zika Virus Genomes","volume":"24","author":"Chazal","year":"2018","journal-title":"Cell Rep."},{"key":"ref_103","doi-asserted-by":"crossref","first-page":"13350","DOI":"10.1128\/JVI.79.21.13350-13361.2005","article-title":"Alpha\/Beta Interferon Protects against Lethal West Nile Virus Infection by Restricting Cellular Tropism and Enhancing Neuronal Survival","volume":"79","author":"Samuel","year":"2005","journal-title":"J. Virol."},{"key":"ref_104","doi-asserted-by":"crossref","first-page":"102991","DOI":"10.1016\/j.ebiom.2020.102991","article-title":"Dengue and Zika Virus Infections Are Enhanced by Live Attenuated Dengue Vaccine but Not by Recombinant DSV4 Vaccine Candidate in Mouse Models","volume":"60","author":"Shukla","year":"2020","journal-title":"eBioMedicine"},{"key":"ref_105","doi-asserted-by":"crossref","first-page":"e01469-17","DOI":"10.1128\/JVI.01469-17","article-title":"Prior Dengue Virus Exposure Shapes T Cell Immunity to Zika Virus in Humans","volume":"91","author":"Grifoni","year":"2017","journal-title":"J. Virol."},{"key":"ref_106","first-page":"107","article-title":"Immunohistochemical Characterization of a New Monoclonal Antibody Reactive with Dengue Virus-Infected Cells in Frozen Tissue Using Immunoperoxidase Technique","volume":"14","author":"Bhoopat","year":"1996","journal-title":"Asian Pac. J. Allergy Immunol."},{"key":"ref_107","doi-asserted-by":"crossref","first-page":"1411","DOI":"10.1086\/383043","article-title":"Localization of Dengue Virus in Naturally Infected Human Tissues, by Immunohistochemistry and in Situ Hybridization","volume":"189","author":"Jessie","year":"2004","journal-title":"J. Infect. Dis."},{"key":"ref_108","doi-asserted-by":"crossref","first-page":"2150","DOI":"10.1038\/s41590-023-01654-3","article-title":"Global and Cell Type-Specific Immunological Hallmarks of Severe Dengue Progression Identified via a Systems Immunology Approach","volume":"24","author":"Ghita","year":"2023","journal-title":"Nat. Immunol."},{"key":"ref_109","doi-asserted-by":"crossref","unstructured":"Yam-Puc, J.C., Cedillo-Barr\u00f3n, L., Aguilar-Medina, E.M., Ramos-Pay\u00e1n, R., Escobar-Guti\u00e9rrez, A., and Flores-Romo, L. (2016). The Cellular Bases of Antibody Responses during Dengue Virus Infection. Front. Immunol., 7.","DOI":"10.3389\/fimmu.2016.00218"},{"key":"ref_110","doi-asserted-by":"crossref","first-page":"80","DOI":"10.4049\/jimmunol.1103350","article-title":"Association between Magnitude of the Virus-Specific Plasmablast Response and Disease Severity in Dengue Patients","volume":"190","author":"Cordeiro","year":"2013","journal-title":"J. Immunol."},{"key":"ref_111","doi-asserted-by":"crossref","unstructured":"Upasani, V., Vo, H.T.M., Ung, S., Heng, S., Laurent, D., Choeung, R., Duong, V., Sorn, S., Ly, S., and Rodenhuis-Zybert, I.A. (2019). Impaired Antibody-Independent Immune Response of B Cells in Patients with Acute Dengue Infection. Front. Immunol., 10.","DOI":"10.3389\/fimmu.2019.02500"},{"key":"ref_112","doi-asserted-by":"crossref","first-page":"5574","DOI":"10.1128\/JVI.03203-15","article-title":"B Cell Responses during Secondary Dengue Virus Infection Are Dominated by Highly Cross-Reactive, Memory-Derived Plasmablasts","volume":"90","author":"Priyamvada","year":"2016","journal-title":"J. Virol."},{"key":"ref_113","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1086\/651018","article-title":"Mechanisms of Immune Evasion Induced by a Complex of Dengue Virus and Preexisting Enhancing Antibodies","volume":"201","author":"Ubol","year":"2010","journal-title":"J. Infect. Dis."},{"key":"ref_114","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1099\/vir.0.82537-0","article-title":"Dengue Virus (DENV) Antibody-Dependent Enhancement of Infection Upregulates the Production of Anti-Inflammatory Cytokines, but Suppresses Anti-DENV Free Radical and pro-Inflammatory Cytokine Production, in THP-1 Cells","volume":"88","author":"Chareonsirisuthigul","year":"2007","journal-title":"J. Gen. Virol."},{"key":"ref_115","unstructured":"(2025, September 03). Japanese Encephalitis. Available online: https:\/\/www.who.int\/news-room\/fact-sheets\/detail\/japanese-encephalitis."},{"key":"ref_116","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/j.pneurobio.2010.01.008","article-title":"Overview: Japanese Encephalitis","volume":"91","author":"Misra","year":"2010","journal-title":"Prog. Neurobiol."},{"key":"ref_117","doi-asserted-by":"crossref","first-page":"192","DOI":"10.4110\/in.2017.17.3.192","article-title":"Exacerbation of Japanese Encephalitis by CD11chi Dendritic Cell Ablation Is Associated with an Imbalance in Regulatory Foxp3+ and IL-17+CD4+ Th17 Cells and in Ly-6Chi and Ly-6Clo Monocytes","volume":"17","author":"Choi","year":"2017","journal-title":"Immune Netw."},{"key":"ref_118","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1038\/s41467-019-08641-z","article-title":"Japanese Encephalitis Virus Neuropenetrance Is Driven by Mast Cell Chymase","volume":"10","author":"Hsieh","year":"2019","journal-title":"Nat. Commun."},{"key":"ref_119","doi-asserted-by":"crossref","first-page":"1150","DOI":"10.1128\/JVI.02738-13","article-title":"Infection of Pericytes in Vitro by Japanese Encephalitis Virus Disrupts the Integrity of the Endothelial Barrier","volume":"88","author":"Chen","year":"2014","journal-title":"J. Virol."},{"key":"ref_120","doi-asserted-by":"crossref","first-page":"1915","DOI":"10.1002\/glia.22857","article-title":"Disruption of in Vitro Endothelial Barrier Integrity by Japanese Encephalitis Virus-Infected Astrocytes","volume":"63","author":"Chang","year":"2015","journal-title":"Glia"},{"key":"ref_121","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1016\/j.neuint.2011.02.022","article-title":"Src Signaling Involvement in Japanese Encephalitis Virus-Induced Cytokine Production in Microglia","volume":"58","author":"Chen","year":"2011","journal-title":"Neurochem. Int."},{"key":"ref_122","doi-asserted-by":"crossref","first-page":"5602","DOI":"10.1128\/JVI.00143-15","article-title":"Viral Infection of the Central Nervous System and Neuroinflammation Precede Blood-Brain Barrier Disruption during Japanese Encephalitis Virus Infection","volume":"89","author":"Li","year":"2015","journal-title":"J. Virol."},{"key":"ref_123","doi-asserted-by":"crossref","unstructured":"Kaushik, D.K., Gupta, M., Kumawat, K.L., and Basu, A. (2012). NLRP3 Inflammasome: Key Mediator of Neuroinflammation in Murine Japanese Encephalitis. PLoS ONE, 7, Available online: https:\/\/journals.plos.org\/plosone\/article?id=10.1371\/journal.pone.0032270.","DOI":"10.1371\/journal.pone.0032270"},{"key":"ref_124","doi-asserted-by":"crossref","unstructured":"Singh, S., Singh, G., Tiwari, S., and Kumar, A. (2020). CCR2 Inhibition Reduces Neurotoxic Microglia Activation Phenotype After Japanese Encephalitis Viral Infection. Front. Cell. Neurosci., 14.","DOI":"10.3389\/fncel.2020.00230"},{"key":"ref_125","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1111\/jnc.14645","article-title":"Japanese Encephalitis Virus-Induced Let-7a\/b Interacted with the NOTCH-TLR7 Pathway in Microglia and Facilitated Neuronal Death via Caspase Activation","volume":"149","author":"Mukherjee","year":"2019","journal-title":"J. Neurochem."},{"key":"ref_126","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/j.nbd.2014.05.036","article-title":"TLR7 Is a Key Regulator of Innate Immunity against Japanese Encephalitis Virus Infection","volume":"69","author":"Nazmi","year":"2014","journal-title":"Neurobiol. Dis."},{"key":"ref_127","doi-asserted-by":"crossref","unstructured":"Awais, M., Wang, K., Lin, X., Qian, W., Zhang, N., Wang, C., Wang, K., Zhao, L., Fu, Z.F., and Cui, M. (2017). TLR7 Deficiency Leads to TLR8 Compensative Regulation of Immune Response against JEV in Mice. Front. Immunol., 8.","DOI":"10.3389\/fimmu.2017.00160"},{"key":"ref_128","doi-asserted-by":"crossref","first-page":"127143","DOI":"10.1016\/j.vaccine.2025.127143","article-title":"Neutralizing Antibodies against the Japanese Encephalitis Virus Are Produced by a 12 kDa E. coli- Expressed Envelope Protein Domain III (EDIII) Tagged with a Solubility-Controlling Peptide","volume":"56","author":"Islam","year":"2025","journal-title":"Vaccine"},{"key":"ref_129","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1186\/1743-422X-9-135","article-title":"Protective Immunity to Japanese Encephalitis Virus Associated with Anti-NS1 Antibodies in a Mouse Model","volume":"9","author":"Li","year":"2012","journal-title":"Virol. J."},{"key":"ref_130","doi-asserted-by":"crossref","first-page":"3094","DOI":"10.4049\/jimmunol.1700671","article-title":"Myeloid-Derived Suppressor Cells Inhibit T Follicular Helper Cell Immune Response in Japanese Encephalitis Virus Infection","volume":"199","author":"Wang","year":"2017","journal-title":"J. Immunol."},{"key":"ref_131","unstructured":"(2025, September 03). West Nile Virus. Available online: https:\/\/www.who.int\/news-room\/fact-sheets\/detail\/west-nile-virus."},{"key":"ref_132","first-page":"1","article-title":"Surveillance for Human West Nile Virus Disease\u2014United States, 1999\u20132008","volume":"59","author":"Lindsey","year":"2010","journal-title":"MMWR Surveill. Summ."},{"key":"ref_133","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1046\/j.1523-1747.2000.00904.x","article-title":"Langerhans Cells Migrate to Local Lymph Nodes Following Cutaneous Infection with an Arbovirus","volume":"114","author":"Johnston","year":"2000","journal-title":"J. Investig. Dermatol."},{"key":"ref_134","doi-asserted-by":"crossref","first-page":"2660","DOI":"10.1099\/vir.0.011783-0","article-title":"Toll-like Receptor 7-Induced Immune Response to Cutaneous West Nile Virus Infection","volume":"90","author":"Welte","year":"2009","journal-title":"J. Gen. Virol."},{"key":"ref_135","doi-asserted-by":"crossref","first-page":"8339","DOI":"10.1128\/JVI.79.13.8339-8347.2005","article-title":"Envelope Protein Glycosylation Status Influences Mouse Neuroinvasion Phenotype of Genetic Lineage 1 West Nile Virus Strains","volume":"79","author":"Beasley","year":"2005","journal-title":"J. Virol."},{"key":"ref_136","doi-asserted-by":"crossref","first-page":"3059","DOI":"10.1172\/JCI32218","article-title":"Abrogation of Macrophage Migration Inhibitory Factor Decreases West Nile Virus Lethality by Limiting Viral Neuroinvasion","volume":"117","author":"Arjona","year":"2007","journal-title":"J. Clin. Investig."},{"key":"ref_137","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1038\/nrmicro2950","article-title":"West Nile Virus Infection and Immunity","volume":"11","author":"Suthar","year":"2013","journal-title":"Nat. Rev. Microbiol."},{"key":"ref_138","doi-asserted-by":"crossref","first-page":"17140","DOI":"10.1073\/pnas.0705837104","article-title":"Axonal Transport Mediates West Nile Virus Entry into the Central Nervous System and Induces Acute Flaccid Paralysis","volume":"104","author":"Samuel","year":"2007","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_139","doi-asserted-by":"crossref","first-page":"8363","DOI":"10.1128\/JVI.01097-13","article-title":"A Role for Ifit2 in Restricting West Nile Virus Infection in the Brain","volume":"87","author":"Cho","year":"2013","journal-title":"J. Virol."},{"key":"ref_140","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1038\/nm.3108","article-title":"Differential Innate Immune Response Programs in Neuronal Subtypes Determine Susceptibility to Infection in the Brain by Positive-Stranded RNA Viruses","volume":"19","author":"Cho","year":"2013","journal-title":"Nat. Med."},{"key":"ref_141","doi-asserted-by":"crossref","first-page":"10349","DOI":"10.1128\/JVI.00935-08","article-title":"Toll-like Receptor 3 Has a Protective Role against West Nile Virus Infection","volume":"82","author":"Daffis","year":"2008","journal-title":"J. Virol."},{"key":"ref_142","doi-asserted-by":"crossref","unstructured":"Ramos, H.J., Lanteri, M.C., Blahnik, G., Negash, A., Suthar, M.S., Brassil, M.M., Sodhi, K., Treuting, P.M., Busch, M.P., and Norris, P.J. (2012). IL-1\u03b2 Signaling Promotes CNS-Intrinsic Immune Control of West Nile Virus Infection. PLoS Pathog., 8.","DOI":"10.1371\/journal.ppat.1003039"},{"key":"ref_143","doi-asserted-by":"crossref","first-page":"12125","DOI":"10.1128\/JVI.01026-10","article-title":"The Innate Immune Adaptor Molecule MyD88 Restricts West Nile Virus Replication and Spread in Neurons of the Central Nervous System","volume":"84","author":"Szretter","year":"2010","journal-title":"J. Virol."},{"key":"ref_144","unstructured":"(2025, September 03). Caspase-12 Controls West Nile Virus Infection via the Viral RNA Receptor RIG-I|Nature Immunology. Available online: https:\/\/www.nature.com\/articles\/ni.1933."},{"key":"ref_145","doi-asserted-by":"crossref","first-page":"3804","DOI":"10.4049\/jimmunol.176.6.3804","article-title":"Microglia Recognize Double-Stranded RNA via TLR3","volume":"176","author":"Town","year":"2006","journal-title":"J. Immunol."},{"key":"ref_146","doi-asserted-by":"crossref","first-page":"2814","DOI":"10.1128\/JVI.02577-12","article-title":"Differential Replication of Pathogenic and Nonpathogenic Strains of West Nile Virus within Astrocytes","volume":"87","author":"Hussmann","year":"2013","journal-title":"J. Virol."},{"key":"ref_147","doi-asserted-by":"crossref","first-page":"11457","DOI":"10.1128\/JVI.79.17.11457-11466.2005","article-title":"Neuronal CXCL10 Directs CD8+ T-Cell Recruitment and Control of West Nile Virus Encephalitis","volume":"79","author":"Klein","year":"2005","journal-title":"J. Virol."},{"key":"ref_148","doi-asserted-by":"crossref","first-page":"1291","DOI":"10.1038\/s41590-019-0477-z","article-title":"A Protective Zika Virus E-Dimer-Based Subunit Vaccine Engineered to Abrogate Antibody-Dependent Enhancement of Dengue Infection","volume":"20","author":"Dejnirattisai","year":"2019","journal-title":"Nat. Immunol."},{"key":"ref_149","doi-asserted-by":"crossref","unstructured":"Rothen, D.A., Dutta, S.K., Krenger, P.S., Pardini, A., Vogt, A.-C.S., Josi, R., Lieknina, I., Osterhaus, A.D.M.E., Mohsen, M.O., and Vogel, M. (2024). Preclinical Development of a Novel Zika Virus-like Particle Vaccine in Combination with Tetravalent Dengue Virus-like Particle Vaccines. Vaccines, 12.","DOI":"10.3390\/vaccines12091053"},{"key":"ref_150","doi-asserted-by":"crossref","first-page":"2046960","DOI":"10.1080\/21645515.2022.2046960","article-title":"A Phase I Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Safety, Tolerability, and Immunogenicity of a Live-Attenuated Quadrivalent Dengue Vaccine in Flavivirus-Na\u00efve and Flavivirus-Experienced Healthy Adults","volume":"18","author":"Russell","year":"2022","journal-title":"Hum. Vaccines Immunother."},{"key":"ref_151","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1038\/s41591-019-0746-2","article-title":"Potent Zika and Dengue Cross-Neutralizing Antibodies Induced by Zika Vaccination in a Dengue-Experienced Donor","volume":"26","author":"Dussupt","year":"2020","journal-title":"Nat. Med."},{"key":"ref_152","doi-asserted-by":"crossref","unstructured":"Horbach, I.S., de Souza Azevedo, A., Schwarcz, W.D., Alves, N.D.S., de Moura Dias, B., Setatino, B.P., da Cruz Moura, L., de Souza, A.F., Denani, C.B., and da Silva, S.A. (2024). Plaque Reduction Neutralization Test (PRNT) Accuracy in Evaluating Humoral Immune Response to SARS-CoV-2. Diseases, 12.","DOI":"10.3390\/diseases12010029"},{"key":"ref_153","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1016\/S1473-3099(22)00764-2","article-title":"The Safety and Immunogenicity of Two Zika Virus mRNA Vaccine Candidates in Healthy Flavivirus Baseline Seropositive and Seronegative Adults: The Results of Two Randomised, Placebo-Controlled, Dose-Ranging, Phase 1 Clinical Trials","volume":"23","author":"Essink","year":"2023","journal-title":"Lancet Infect. Dis."},{"key":"ref_154","doi-asserted-by":"crossref","unstructured":"(2023). Correction to: Persistence of Immunogenicity of a Purified Inactivated Zika Virus Vaccine Candidate in Healthy Adults: 2 Years of Follow-up Compared with Natural Infection. J. Infect. Dis., 228, 1309.","DOI":"10.1093\/infdis\/jiad375"},{"key":"ref_155","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1016\/j.chom.2010.10.007","article-title":"Mouse STAT2 Restricts Early Dengue Virus Replication","volume":"8","author":"Ashour","year":"2010","journal-title":"Cell Host Microbe"},{"key":"ref_156","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.dci.2005.06.006","article-title":"Similarity and Divergence in the Development and Expression of the Mouse and Human Antibody Repertoires","volume":"30","author":"Schroeder","year":"2006","journal-title":"Dev. Comp. Immunol."},{"key":"ref_157","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.1093\/oxfordjournals.molbev.a025709","article-title":"Sequence Convergence in the Peptide-Binding Region of Primate and Rodent MHC Class Ib Molecules","volume":"14","author":"Yeager","year":"1997","journal-title":"Mol. Biol. Evol."},{"key":"ref_158","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1186\/1743-422X-7-28","article-title":"Neutralizing and Non-Neutralizing Monoclonal Antibodies against Dengue Virus E Protein Derived from a Naturally Infected Patient","volume":"7","author":"Schieffelin","year":"2010","journal-title":"Virol. J."},{"key":"ref_159","doi-asserted-by":"crossref","first-page":"5847","DOI":"10.1128\/JVI.00216-15","article-title":"Dengue Virus Infection with Highly Neutralizing Levels of Cross-Reactive Antibodies Causes Acute Lethal Small Intestinal Pathology without a High Level of Viremia in Mice","volume":"89","author":"Watanabe","year":"2015","journal-title":"J. Virol."},{"key":"ref_160","doi-asserted-by":"crossref","first-page":"112","DOI":"10.4269\/ajtmh.19-0633","article-title":"Virological and Immunological Outcomes in Rhesus Monkeys after Exposure to Dengue Virus\u2013Infected Aedes Aegypti Mosquitoes","volume":"103","author":"Carrington","year":"2020","journal-title":"Am. J. Trop. Med. Hyg."},{"key":"ref_161","doi-asserted-by":"crossref","first-page":"672","DOI":"10.4269\/ajtmh.13-0492","article-title":"Infection Dynamics of Sylvatic Dengue Virus in a Natural Primate Host, the African Green Monkey","volume":"91","author":"Hanley","year":"2014","journal-title":"Am. J. Trop. Med. Hyg."},{"key":"ref_162","doi-asserted-by":"crossref","first-page":"e11212","DOI":"10.1016\/j.heliyon.2022.e11212","article-title":"Monocytes as Suitable Carriers for Dissemination of Dengue Viral Infection","volume":"8","author":"Hwang","year":"2022","journal-title":"Heliyon"},{"key":"ref_163","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1038\/nature18296","article-title":"The Brazilian Zika Virus Strain Causes Birth Defects in Experimental Models","volume":"534","author":"Cugola","year":"2016","journal-title":"Nature"},{"key":"ref_164","doi-asserted-by":"crossref","first-page":"2205","DOI":"10.1128\/JVI.03085-13","article-title":"Utility of Humanized BLT Mice for Analysis of Dengue Virus Infection and Antiviral Drug Testing","volume":"88","author":"Dorner","year":"2014","journal-title":"J. Virol."},{"key":"ref_165","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1016\/j.chom.2018.04.003","article-title":"An Immunocompetent Mouse Model of Zika Virus Infection","volume":"23","author":"Gorman","year":"2018","journal-title":"Cell Host Microbe"},{"key":"ref_166","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1086\/431520","article-title":"Dengue Virus (DV) Enhancing Antibody Activity in Preillness Plasma Does Not Predict Subsequent Disease Severity or Viremia in Secondary DV Infection","volume":"192","author":"Laoprasopwattana","year":"2005","journal-title":"J. Infect. Dis."},{"key":"ref_167","doi-asserted-by":"crossref","first-page":"1559","DOI":"10.1016\/S0140-6736(12)61428-7","article-title":"Protective Efficacy of the Recombinant, Live-Attenuated, CYD Tetravalent Dengue Vaccine in Thai Schoolchildren: A Randomised, Controlled Phase 2b Trial","volume":"380","author":"Sabchareon","year":"2012","journal-title":"Lancet"},{"key":"ref_168","doi-asserted-by":"crossref","unstructured":"Rainwater-Lovett, K., Rodriguez-Barraquer, I., Cummings, D.A., and Lessler, J. (2012). Variation in Dengue Virus Plaque Reduction Neutralization Testing: Systematic Review and Pooled Analysis. BMC Infect. Dis., 12.","DOI":"10.1186\/1471-2334-12-233"},{"key":"ref_169","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.virol.2016.06.022","article-title":"Enhancing Dengue Virus Maturation Using a Stable Furin Over-Expressing Cell Line","volume":"497","author":"Mukherjee","year":"2016","journal-title":"Virology"},{"key":"ref_170","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1056\/NEJMoa1800820","article-title":"Effect of Dengue Serostatus on Dengue Vaccine Safety and Efficacy","volume":"379","author":"Sridhar","year":"2018","journal-title":"N. Engl. J. Med."},{"key":"ref_171","doi-asserted-by":"crossref","first-page":"2009","DOI":"10.1056\/NEJMoa1903869","article-title":"Efficacy of a Tetravalent Dengue Vaccine in Healthy Children and Adolescents","volume":"381","author":"Biswal","year":"2019","journal-title":"N. Engl. J. Med."},{"key":"ref_172","doi-asserted-by":"crossref","first-page":"968262","DOI":"10.1155\/2014\/968262","article-title":"Evidence of HLA-DQB1 Contribution to Susceptibility of Dengue Serotype 3 in Dengue Patients in Southern Brazil","volume":"2014","author":"Cardozo","year":"2014","journal-title":"J. Trop. Med."},{"key":"ref_173","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1093\/infdis\/jiw309","article-title":"HLA-DRB1 Alleles Are Associated with Different Magnitudes of Dengue Virus\u2013Specific CD4+ T-Cell Responses","volume":"214","author":"Weiskopf","year":"2016","journal-title":"J. Infect. Dis."},{"key":"ref_174","first-page":"648475","article-title":"HLA-B\u221744 is Associated with Dengue Severity Caused by DENV-3 in a Brazilian Population","volume":"2013","author":"Gil","year":"2013","journal-title":"J. Trop. Med."},{"key":"ref_175","doi-asserted-by":"crossref","first-page":"2546","DOI":"10.1080\/07391102.2018.1491890","article-title":"Exploring Dengue Proteome to Design an Effective Epitope-Based Vaccine against Dengue Virus","volume":"37","author":"Sabetian","year":"2019","journal-title":"J. Biomol. Struct. Dyn."},{"key":"ref_176","doi-asserted-by":"crossref","unstructured":"Roth, C., Cantaert, T., Colas, C., Prot, M., Casad\u00e9mont, I., Levillayer, L., Thalmensi, J., Langlade-Demoyen, P., Gerke, C., and Bahl, K. (2019). A Modified mRNA Vaccine Targeting Immunodominant NS Epitopes Protects Against Dengue Virus Infection in HLA Class I Transgenic Mice. Front. Immunol., 10.","DOI":"10.3389\/fimmu.2019.01424"},{"key":"ref_177","doi-asserted-by":"crossref","first-page":"e01773-23","DOI":"10.1128\/jvi.01773-23","article-title":"Epitope(s) Involving Amino Acids of the Fusion Loop of Japanese Encephalitis Virus Envelope Protein Is (Are) Important to Elicit Protective Immunity","volume":"98","author":"Fan","year":"2024","journal-title":"J. Virol."},{"key":"ref_178","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1186\/1743-422X-9-115","article-title":"Manipulation of Immunodominant Dengue Virus E Protein Epitopes Reduces Potential Antibody-Dependent Enhancement","volume":"9","author":"Hughes","year":"2012","journal-title":"Virol. J."},{"key":"ref_179","doi-asserted-by":"crossref","unstructured":"Kotaki, T., Nagai, Y., Yamanaka, A., Konishi, E., and Kameoka, M. (2022). Japanese Encephalitis DNA Vaccines with Epitope Modification Reduce the Induction of Cross-Reactive Antibodies against Dengue Virus and Antibody-Dependent Enhancement of Dengue Virus Infection. Vaccines, 10.","DOI":"10.3390\/vaccines10091411"},{"key":"ref_180","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1016\/S0092-8674(02)00660-8","article-title":"Structure of Dengue Virus: Implications for Flavivirus Organization, Maturation, and Fusion","volume":"108","author":"Kuhn","year":"2002","journal-title":"Cell"},{"key":"ref_181","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1038\/nature02165","article-title":"Structure of the Dengue Virus Envelope Protein after Membrane Fusion","volume":"427","author":"Modis","year":"2004","journal-title":"Nature"},{"key":"ref_182","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1126\/science.aan6836","article-title":"Antibody-Dependent Enhancement of Severe Dengue Disease in Humans","volume":"358","author":"Katzelnick","year":"2017","journal-title":"Science"},{"key":"ref_183","doi-asserted-by":"crossref","first-page":"15411","DOI":"10.1038\/ncomms15411","article-title":"Covalently Linked Dengue Virus Envelope Glycoprotein Dimers Reduce Exposure of the Immunodominant Fusion Loop Epitope","volume":"8","author":"Rouvinski","year":"2017","journal-title":"Nat. Commun."},{"key":"ref_184","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1128\/JVI.00745-20","article-title":"Dimerization of Dengue Virus E Subunits Impacts Antibody Function and Domain Focus","volume":"94","author":"Thomas","year":"2020","journal-title":"J. Virol."},{"key":"ref_185","doi-asserted-by":"crossref","first-page":"4105","DOI":"10.1016\/j.vaccine.2015.06.067","article-title":"Preclinical Development of a Dengue Tetravalent Recombinant Subunit Vaccine: Immunogenicity and Protective Efficacy in Nonhuman Primates","volume":"33","author":"Govindarajan","year":"2015","journal-title":"Vaccine"},{"key":"ref_186","doi-asserted-by":"crossref","first-page":"eadq0571","DOI":"10.1126\/scitranslmed.adq0571","article-title":"Protective Envelope Dimer Epitope-like Antibodies Are Elicited against Dengue Virus in Children after Infection and Vaccination","volume":"17","author":"Mpingabo","year":"2025","journal-title":"Sci. Transl. Med."},{"key":"ref_187","doi-asserted-by":"crossref","unstructured":"Gallichotte, E.N., Baric, T.J., Yount, B.L., Widman, D.G., Durbin, A., Whitehead, S., Baric, R.S., and de Silva, A.M. (2018). Human Dengue Virus Serotype 2 Neutralizing Antibodies Target Two Distinct Quaternary Epitopes. PLoS Pathog., 14.","DOI":"10.1371\/journal.ppat.1006934"},{"key":"ref_188","doi-asserted-by":"crossref","first-page":"e00818","DOI":"10.1128\/mbio.00818-23","article-title":"Dengue Virus 4\/2 Envelope Domain Chimeric Virus Panel Maps Type-Specific Responses against Dengue Serotype 2","volume":"14","author":"Zhu","year":"2023","journal-title":"mBio"},{"key":"ref_189","doi-asserted-by":"crossref","first-page":"eabg4084","DOI":"10.1126\/sciadv.abg4084","article-title":"Designed, Highly Expressing, Thermostable Dengue Virus 2 Envelope Protein Dimers Elicit Quaternary Epitope Antibodies","volume":"7","author":"Kudlacek","year":"2021","journal-title":"Sci. Adv."},{"key":"ref_190","doi-asserted-by":"crossref","first-page":"e00229-25","DOI":"10.1128\/jvi.00229-25","article-title":"Stabilized Dengue Virus 2 Envelope Subunit Vaccine Redirects the Neutralizing Antibody Response to All E-Domains","volume":"99","author":"Thiono","year":"2025","journal-title":"J. Virol."},{"key":"ref_191","doi-asserted-by":"crossref","unstructured":"Millman, I., Eisenstein, T.K., and Blumberg, B.S. (1984). Newly Licensed Hepatitis B Vaccine. Hepatitis B: The Virus, the Disease, and the Vaccine, Springer.","DOI":"10.1007\/978-1-4899-0369-3"},{"key":"ref_192","doi-asserted-by":"crossref","first-page":"1645","DOI":"10.1056\/NEJMoa020586","article-title":"Proof of Principle Study Investigators A Controlled Trial of a Human Papillomavirus Type 16 Vaccine","volume":"347","author":"Koutsky","year":"2002","journal-title":"N. Engl. J. Med."},{"key":"ref_193","doi-asserted-by":"crossref","unstructured":"Yang, Y., Shi, W., Abiona, O.M., Nazzari, A., Olia, A.S., Ou, L., Phung, E., Stephens, T., Tsybovsky, Y., and Verardi, R. (2021). Newcastle Disease Virus-Like Particles Displaying Prefusion-Stabilized SARS-CoV-2 Spikes Elicit Potent Neutralizing Responses. Vaccines, 9.","DOI":"10.3390\/vaccines9020073"},{"key":"ref_194","doi-asserted-by":"crossref","unstructured":"Lee, S.-H., Chu, K.-B., Kim, M.-J., Mao, J., Eom, G.-D., Yoon, K.-W., Ahmed, M.A., and Quan, F.-S. (2023). Virus-like Particle Vaccine Expressing the Respiratory Syncytial Virus Pre-Fusion and G Proteins Confers Protection against RSV Challenge Infection. Pharmaceutics, 15.","DOI":"10.3390\/pharmaceutics15030782"},{"key":"ref_195","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1038\/s41541-025-01163-4","article-title":"A VLPs Based Vaccine Protects against Zika Virus Infection and Prevents Cerebral and Testicular Damage","volume":"10","author":"Lira","year":"2025","journal-title":"npj Vaccines"},{"key":"ref_196","doi-asserted-by":"crossref","unstructured":"Liu, Y., Zhou, J., Yu, Z., Fang, D., Fu, C., Zhu, X., He, Z., Yan, H., and Jiang, L. (2014). Tetravalent Recombinant Dengue Virus-like Particles as Potential Vaccine Candidates: Immunological Properties. BMC Microbiol., 14.","DOI":"10.1186\/s12866-014-0233-3"},{"key":"ref_197","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1007\/978-1-4939-3389-1_25","article-title":"Production of Japanese Encephalitis Virus-Like Particles Using Insect Cell Expression Systems","volume":"1404","author":"Yamaji","year":"2016","journal-title":"Methods Mol. Biol."},{"key":"ref_198","doi-asserted-by":"crossref","first-page":"7679","DOI":"10.1038\/s41598-017-08247-9","article-title":"Virus-like Particles That Display Zika Virus Envelope Protein Domain III Induce Potent Neutralizing Immune Responses in Mice","volume":"7","author":"Yang","year":"2017","journal-title":"Sci. Rep."},{"key":"ref_199","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1038\/ni0515-544b","article-title":"Correction: Corrigendum: A New Class of Highly Potent, Broadly Neutralizing Antibodies Isolated from Viremic Patients Infected with Dengue Virus","volume":"16","author":"Dejnirattisai","year":"2015","journal-title":"Nat. Immunol."},{"key":"ref_200","doi-asserted-by":"crossref","first-page":"e00239-24","DOI":"10.1128\/jvi.00239-24","article-title":"A Tetravalent Dengue Virus-like Particle Vaccine Induces High Levels of Neutralizing Antibodies and Reduces Dengue Replication in Non-Human Primates","volume":"98","author":"Thoresen","year":"2024","journal-title":"J. Virol."},{"key":"ref_201","doi-asserted-by":"crossref","first-page":"e01181-17","DOI":"10.1128\/JVI.01181-17","article-title":"An Envelope-Modified Tetravalent Dengue Virus-Like-Particle Vaccine Has Implications for Flavivirus Vaccine Design","volume":"91","author":"Urakami","year":"2017","journal-title":"J. Virol."},{"key":"ref_202","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/j.jviromet.2014.04.019","article-title":"An Optimized Expression Vector for Improving the Yield of Dengue Virus-like Particles from Transfected Insect Cells","volume":"205","author":"Charoensri","year":"2014","journal-title":"J. Virol. Methods"},{"key":"ref_203","doi-asserted-by":"crossref","first-page":"7728","DOI":"10.1016\/j.vaccine.2018.10.072","article-title":"Dengue-2 Virus-like Particle (VLP) Based Vaccine Elicits the Highest Titers of Neutralizing Antibodies When Produced at Reduced Temperature","volume":"36","author":"Boigard","year":"2018","journal-title":"Vaccine"},{"key":"ref_204","doi-asserted-by":"crossref","first-page":"6795","DOI":"10.1073\/pnas.1304300110","article-title":"Dengue Structure Differs at the Temperatures of Its Human and Mosquito Hosts","volume":"110","author":"Zhang","year":"2013","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_205","doi-asserted-by":"crossref","first-page":"2658","DOI":"10.1002\/bit.28392","article-title":"Mimotope Discovery as a Tool to Design a Vaccine against Zika and Dengue Viruses","volume":"120","author":"Kopylov","year":"2023","journal-title":"Biotechnol. Bioeng."},{"key":"ref_206","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1126\/science.aaa8651","article-title":"DENGUE VIRUS. Cryo-EM Structure of an Antibody That Neutralizes Dengue Virus Type 2 by Locking E Protein Dimers","volume":"349","author":"Fibriansah","year":"2015","journal-title":"Science"},{"key":"ref_207","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1038\/emboj.2011.439","article-title":"Structural Insights into the Neutralization Mechanism of a Higher Primate Antibody against Dengue Virus","volume":"31","author":"Cockburn","year":"2012","journal-title":"EMBO J."},{"key":"ref_208","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1080\/22221751.2019.1701953","article-title":"Longitudinal Analysis of the Antibody Repertoire of a Zika Virus-Infected Patient Revealed Dynamic Changes in Antibody Response","volume":"9","author":"Niu","year":"2020","journal-title":"Emerg. Microbes Infect."},{"key":"ref_209","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1128\/CVI.05412-11","article-title":"Poly-\u03b3-Glutamic Acid Nanoparticles and Aluminum Adjuvant Used as an Adjuvant with a Single Dose of Japanese Encephalitis Virus-Like Particles Provide Effective Protection from Japanese Encephalitis Virus","volume":"19","author":"Okamoto","year":"2012","journal-title":"Clin. Vaccine Immunol."},{"key":"ref_210","doi-asserted-by":"crossref","first-page":"6588","DOI":"10.1016\/j.vaccine.2010.07.055","article-title":"Immunogenicity and Efficacy of Two Types of West Nile Virus-like Particles Different in Size and Maturation as a Second-Generation Vaccine Candidate","volume":"28","author":"Ohtaki","year":"2010","journal-title":"Vaccine"},{"key":"ref_211","doi-asserted-by":"crossref","first-page":"13262","DOI":"10.1128\/JVI.79.21.13262-13274.2005","article-title":"N-Linked Glycosylation of West Nile Virus Envelope Proteins Influences Particle Assembly and Infectivity","volume":"79","author":"Hanna","year":"2005","journal-title":"J. Virol."},{"key":"ref_212","doi-asserted-by":"crossref","first-page":"8643","DOI":"10.1038\/s41598-018-26904-5","article-title":"Dengue Envelope-Based \u2018Four-in-One\u2019 Virus-like Particles Produced Using Pichia Pastoris Induce Enhancement-Lacking, Domain III-Directed Tetravalent Neutralising Antibodies in Mice","volume":"8","author":"Rajpoot","year":"2018","journal-title":"Sci. Rep."},{"key":"ref_213","doi-asserted-by":"crossref","first-page":"abm0829","DOI":"10.1126\/science.abm0829","article-title":"mRNA Vaccines Induce Durable Immune Memory to SARS-CoV-2 and Variants of Concern","volume":"374","author":"Goel","year":"2021","journal-title":"Science"},{"key":"ref_214","doi-asserted-by":"crossref","unstructured":"Liu, X. (2025). Opportunities and Challenges of mRNA Technologies in Development of Dengue Virus Vaccine. Front. Immunol., 16.","DOI":"10.3389\/fimmu.2025.1520968"},{"key":"ref_215","doi-asserted-by":"crossref","first-page":"126518","DOI":"10.1016\/j.vaccine.2024.126518","article-title":"Immunogenicity and Protection of a Triple Repeat Domain III mRNA Vaccine against Zika Virus","volume":"43","author":"Lee","year":"2025","journal-title":"Vaccine"},{"key":"ref_216","doi-asserted-by":"crossref","first-page":"1407","DOI":"10.1016\/S0140-6736(21)02183-8","article-title":"Effectiveness of mRNA BNT162b2 COVID-19 Vaccine up to 6 Months in a Large Integrated Health System in the USA: A Retrospective Cohort Study","volume":"398","author":"Tartof","year":"2021","journal-title":"Lancet"},{"key":"ref_217","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.1016\/j.cell.2021.01.037","article-title":"Circulating SARS-CoV-2 Spike N439K Variants Maintain Fitness While Evading Antibody-Mediated Immunity","volume":"184","author":"Thomson","year":"2021","journal-title":"Cell"},{"key":"ref_218","doi-asserted-by":"crossref","first-page":"e187405","DOI":"10.1172\/jci.insight.187405","article-title":"Enhanced Durability of a Zika Virus Self-Amplifying RNA Vaccine through Combinatorial OX40 and 4-1BB Agonism","volume":"10","author":"Lu","year":"2025","journal-title":"JCI Insight"},{"key":"ref_219","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1038\/s41541-022-00590-x","article-title":"A Phase I\/II Randomized, Double-Blinded, Placebo-Controlled Trial of a Self-Amplifying Covid-19 mRNA Vaccine","volume":"7","author":"Low","year":"2022","journal-title":"npj Vaccines"},{"key":"ref_220","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1038\/s41417-023-00587-1","article-title":"Clinical Trials of Self-Replicating RNA-Based Cancer Vaccines","volume":"30","author":"Morse","year":"2023","journal-title":"Cancer Gene Ther."},{"key":"ref_221","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1038\/s41467-025-55843-9","article-title":"Safety and Immunogenicity of an Optimized Self-Replicating RNA Platform for Low Dose or Single Dose Vaccine Applications: A Randomized, Open Label Phase I Study in Healthy Volunteers","volume":"16","author":"Maine","year":"2025","journal-title":"Nat. Commun."},{"key":"ref_222","doi-asserted-by":"crossref","first-page":"127216","DOI":"10.1016\/j.vaccine.2025.127216","article-title":"Enhanced Immunogenicity of an mRNA Vaccine against Dengue Virus Serotype 2 with Modified Key Residue","volume":"57","author":"Kumari","year":"2025","journal-title":"Vaccine"},{"key":"ref_223","doi-asserted-by":"crossref","unstructured":"Zhu, J., He, C., Liu, Y., Chen, M., Zhang, J., Chen, D., Ni, H., and Wen, J. (2024). An Engineered Japanese Encephalitis Virus mRNA-Lipid Nanoparticle Immunization Induces Protective Immunity in Mice. Front. Microbiol., 15.","DOI":"10.3389\/fmicb.2024.1472824"},{"key":"ref_224","doi-asserted-by":"crossref","first-page":"6004","DOI":"10.1016\/j.vaccine.2022.09.012","article-title":"Engineered Flavivirus Vaccines Control Induction of Crossreactive Infection-Enhancing and -Neutralizing Antibodies","volume":"40","author":"Yamanaka","year":"2022","journal-title":"Vaccine"},{"key":"ref_225","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/j.chom.2010.08.007","article-title":"The Human Immune Response to Dengue Virus Is Dominated by Highly Cross-Reactive Antibodies Endowed with Neutralizing and Enhancing Activity","volume":"8","author":"Beltramello","year":"2010","journal-title":"Cell Host Microbe"},{"key":"ref_226","doi-asserted-by":"crossref","first-page":"7439","DOI":"10.1073\/pnas.1200566109","article-title":"Identification of Human Neutralizing Antibodies That Bind to Complex Epitopes on Dengue Virions","volume":"109","author":"Smith","year":"2012","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_227","doi-asserted-by":"crossref","first-page":"15674","DOI":"10.1038\/ncomms15674","article-title":"Zika Virus Pathogenesis in Rhesus Macaques Is Unaffected by Pre-Existing Immunity to Dengue Virus","volume":"8","author":"Pantoja","year":"2017","journal-title":"Nat. Commun."},{"key":"ref_228","doi-asserted-by":"crossref","first-page":"4117","DOI":"10.4049\/jimmunol.1401597","article-title":"CD8+ T Cells Prevent Antigen-Induced Antibody-Dependent Enhancement of Dengue Disease in Mice","volume":"193","author":"Zellweger","year":"2014","journal-title":"J. Immunol."},{"key":"ref_229","first-page":"e01415","article-title":"Zika Virus-Like Particles Bearing a Covalent Dimer of Envelope Protein Protect Mice from Lethal Challenge","volume":"95","author":"Tandavanitj","year":"2020","journal-title":"J. Virol."},{"key":"ref_230","doi-asserted-by":"crossref","first-page":"e378","DOI":"10.1016\/S1473-3099(17)30362-6","article-title":"Achieving Safe, Effective, and Durable Zika Virus Vaccines: Lessons from Dengue","volume":"17","author":"Halstead","year":"2017","journal-title":"Lancet Infect. Dis."},{"key":"ref_231","doi-asserted-by":"crossref","unstructured":"Flores, H.E., Pinzon Burgos, E.F., Camacho Ortega, S., Heredia, A., and Chua, J.V. (2025). From Antibodies to Immunity: Assessing Correlates of Flavivirus Protection and Cross-Reactivity. Vaccines, 13.","DOI":"10.3390\/vaccines13050449"},{"key":"ref_232","doi-asserted-by":"crossref","first-page":"2693","DOI":"10.1128\/JVI.02675-12","article-title":"Differential Targeting of Viral Components by CD4+ versus CD8+ T Lymphocytes in Dengue Virus Infection","volume":"87","author":"Rivino","year":"2013","journal-title":"J. Virol."},{"key":"ref_233","doi-asserted-by":"crossref","first-page":"E2046","DOI":"10.1073\/pnas.1305227110","article-title":"Comprehensive Analysis of Dengue Virus-Specific Responses Supports an HLA-Linked Protective Role for CD8+ T Cells","volume":"110","author":"Weiskopf","year":"2013","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_234","doi-asserted-by":"crossref","first-page":"e00055-16","DOI":"10.1128\/MMBR.00055-16","article-title":"The Antigenic Structure of Zika Virus and Its Relation to Other Flaviviruses: Implications for Infection and Immunoprophylaxis","volume":"81","author":"Heinz","year":"2017","journal-title":"Microbiol. Mol. Biol. Rev."},{"key":"ref_235","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1038\/s41586-024-07899-8","article-title":"Mapping Glycoprotein Structure Reveals Flaviviridae Evolutionary History","volume":"633","author":"Mifsud","year":"2024","journal-title":"Nature"}],"container-title":["International Journal of Molecular Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1422-0067\/27\/2\/1081\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,24]],"date-time":"2026-01-24T05:28:38Z","timestamp":1769232518000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1422-0067\/27\/2\/1081"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,21]]},"references-count":235,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2026,1]]}},"alternative-id":["ijms27021081"],"URL":"https:\/\/doi.org\/10.3390\/ijms27021081","relation":{},"ISSN":["1422-0067"],"issn-type":[{"value":"1422-0067","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,21]]}}}